- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
The State of Medical Marijuana in Idaho
2020 Grade: F
2019-2020 Improvements and Recommendations
Activists working on gathering signatures for a petition to get medical cannabis on the 2020 ballot as an initiative were forced to suspend their campaign due to COVID, which made signature gathering in the Gem State impossible. ASA encourages state lawmakers to initiate work in 2021 focused on construction of a comprehensive medical cannabis program. Such a program should provide legal protections to patients related to employment, housing, education and family law and develop an in-state production system for lab-tested medical cannabis and cannabis products that can be made available to patients at legal retailers. ASA also recommends that lawmakers authorize patients to cultivate cannabis at home to reduce costs to patients.
Idaho is one of three remaining states without any type of medical cannabis program, leaving patients no safe or legal access to cannabis or cannabis products.
Again this year, surveyed patients report that it is unacceptable for medical cannabis to be illegal in Idaho. Surveyed patients would like to see medical cannabis flower, concentrates, oil, tinctures, lotions, edibles, and patches available in their state.